NASDAQ:GDRX

GoodRx Earnings Date, Estimates & History

$32.07
-0.45 (-1.38 %)
(As of 07/30/2021 12:00 AM ET)
Add
Compare
Today's Range
$31.59
$33.06
50-Day Range
$29.63
$39.63
52-Week Range
$26.66
$64.22
Volume1.42 million shs
Average Volume1.56 million shs
Market Capitalization$12.60 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

GoodRx (NASDAQ:GDRX) Earnings Information

GoodRx last announced its earnings results on May 13th, 2021. The reported $0.07 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.07. The company earned $160.40 million during the quarter, compared to analyst estimates of $160.61 million. Its quarterly revenue was up 20.2% compared to the same quarter last year. GoodRx has generated ($0.96) earnings per share over the last year. Earnings for GoodRx are expected to grow by 325.00% in the coming year, from $0.08 to $0.34 per share. GoodRx has confirmed that its next quarterly earnings report will be published on Thursday, August 12th, 2021. GoodRx will be holding an earnings conference call on Thursday, August 12th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

GoodRx Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GoodRx (NASDAQ:GDRX) Earnings Estimates

Current Year EPS Consensus Estimate: $0.08 EPS
Next Year EPS Consensus Estimate: $0.34 EPS

GoodRx (NASDAQ GDRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
8/12/2021
(Confirmed)
 $0.01       
5/13/20213/31/2021$0.07$0.07($0.02)$160.61 million$160.40 million  
3/11/202112/31/2020$0.06$0.08+$0.02($0.46)$148.01 million$153.50 million  
11/12/20209/30/2020($0.03)$0.09+$0.12($0.29)$135.05 million$140.40 million  
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.